Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2010-03-02

Clinical Trial Update: Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment. [Phase 1]

View source ↗

Summary

Phase 1 trial comparing subconjunctival vitamin C (ascorbic acid) injections to topical or oral treatment for ocular chemical burns has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C (ascorbic acid)

Snippet

Sponsor: The Baruch Padeh Medical Center, Poriya | Conditions: Burn | Phase 1 | Status: WITHDRAWN